| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ... The Lancet 397 (10292), 2361-2371, 2021 | 280 | 2021 |
| Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents MA Dimopoulos, S Delimpasi, E Katodritou, A Vassou, MC Kyrtsonis, ... Annals of oncology 25 (1), 195-200, 2014 | 176 | 2014 |
| Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients: Experience from a single hematology unit MC Kyrtsonis, T Vassilakopoulos, M Angelopoulou, M Siakantaris, ... Annals of hematology 80, 722-727, 2001 | 100 | 2001 |
| Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial E Voskaridou, A Anagnostopoulos, K Konstantopoulos, E Stoupa, ... haematologica 91 (9), 1193-1202, 2006 | 97 | 2006 |
| Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma E Kastritis, E Terpos, M Roussou, M Gavriatopoulou, M Migkou, ... Haematologica 102 (3), 593, 2017 | 94 | 2017 |
| Familial Mediterranean fever associated pyrin mutations in Greece K Konstantopoulos, A Kanta, C Deltas, V Atamian, D Mavrogianni, ... Annals of the rheumatic diseases 62 (5), 479-481, 2003 | 94 | 2003 |
| Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma E Kastritis, F Zagouri, A Symeonidis, M Roussou, A Sioni, A Pouli, ... Leukemia 28 (10), 2075-2079, 2014 | 83 | 2014 |
| Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma TP Vassilakopoulos, MK Angelopoulou, N Constantinou, T Karmiris, ... Blood 105 (5), 1875-1880, 2005 | 77 | 2005 |
| Normative data of the Montreal Cognitive Assessment in the Greek population and parkinsonian dementia K Konstantopoulos, P Vogazianos, T Doskas Archives of Clinical Neuropsychology 31 (3), 246-253, 2016 | 72 | 2016 |
| Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1) Y Rombos, R Tzanetea, K Konstantopoulos, S Simitzis, C Zervas, ... Haematologica 85 (2), 115-117, 2000 | 62 | 2000 |
| Pityriasis rosea associated with imatinib (STI571, Gleevec) K Konstantopoulos, A Papadogianni, M Dimopoulou, C Kourelis, J Meletis Dermatology 205 (2), 172-173, 2002 | 59 | 2002 |
| Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders. J Meletis, E Terpos, M Samarkos, C Meletis, K Konstantopoulos, ... Haematologia 31 (1), 7-16, 2001 | 59 | 2001 |
| Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies F Zagouri, E Kastritis, A Zomas, E Terpos, E Katodritou, A Symeonidis, ... European journal of haematology 99 (5), 409-414, 2017 | 53 | 2017 |
| Erythropoietic response to hypoxaemia in diffuse idiopathic pulmonary fibrosis, as opposed to chronic obstructive pulmonary disease S Tassiopoulos, A Kontos, K Konstantopoulos, C Hadzistavrou, ... Respiratory medicine 95 (6), 471-475, 2001 | 53 | 2001 |
| PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent … TP Vassilakopoulos, GA Pangalis, S Chatziioannou, S Papageorgiou, ... Leukemia 30 (1), 238-242, 2016 | 52 | 2016 |
| Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis E Voskaridou, E Stoupa, L Antoniadou, E Premetis, K Konstantopoulos, ... Haematologica 91 (6), 813-816, 2006 | 49 | 2006 |
| A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? K Konstantopoulos, G Vagiopoulos, R Kantouni, S Lymperi, ... Haematologica 77 (4), 352-354, 1992 | 49 | 1992 |
| The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function MA Dimopoulos, E Kastritis, E Michalis, C Tsatalas, M Michael, A Pouli, ... Annals of Oncology 23 (3), 722-729, 2012 | 45 | 2012 |
| Optimizing outcomes in relapsed/refractory Hodgkin lymphoma: a review of current and forthcoming therapeutic strategies TP Vassilakopoulos, JV Asimakopoulos, K Konstantopoulos, ... Therapeutic advances in hematology 11, 2040620720902911, 2020 | 42 | 2020 |
| No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years E Kastritis, MC Kyrtsonis, E Hatjiharissi, A Symeonidis, E Michalis, ... American journal of hematology 86 (6), 479-483, 2011 | 41 | 2011 |
